scispace - formally typeset
Journal ArticleDOI

Enabling stem cell based therapies: end-to-end solution for human pluripotent stem cells manufacturing

I. Friedrich Ben Nun
- 01 May 2019 - 
- Vol. 21, Iss: 5
Reads0
Chats0
TLDR
This platform avoids 2D cell culture steps, reduces footprint, labor and cost, while enhancing process control and cell product quality, and shows that hPSCs expanded in a bioreactor are shown to have the capability to be directly differentiated in suspension.
About
This article is published in Cytotherapy.The article was published on 2019-05-01. It has received 1 citations till now.

read more

Citations
More filters
Journal ArticleDOI

End-to-End Platform for Human Pluripotent Stem Cell Manufacturing.

TL;DR: A closed, automated and scalable stirred tank bioreactor platform, capable of sustaining high fold expansion of human pluripotent stem cells, that could facilitate the in-process monitoring and integration of online monitoring systems, leading to significantly reduced labor requirements and contamination risk.
Related Papers (5)